The Impact of Tenofovir Alafenamide on Profiles of Body Weight and Metabolic Features in Chronic Hepatitis B Patients.
Clinical trial NCT04886336 · UNKNOWN
Trial details
- NCT number
- NCT04886336
- Sponsor
- National Cheng-Kung University Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-06-04
- Primary completion
- 2022-12-31
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.